INTRODUCTION
Apoptosis is a genetically controlled cellular response to specific stimuli, often requires the activation of specific genes (1) (2) (3) , and can be prevented by inhibitors of RNA and protein synthesis (4) (5) (6) (7) .
Of the 14 caspases identified in mammals, caspase-3 appears to be the major effector in neuronal apoptosis triggered by various stimuli. The first strong evidence supporting the specific role for this protease in neuronal apoptosis came from studies on mice deficient in caspase-3, in which brain development is profoundly altered (8) . A role for caspase-3 in neuronal loss was subsequently established using semi-specific peptide caspase inhibitors in various models of apoptosis triggered by ischemic or traumatic injury in vivo and in vitro (9) (10) (11) (12) (13) (14) (15) (16) (17) .
Because activation of caspases, and caspase-3 in particular, appears to be a major factor for execution of neuronal apoptosis, evaluation of upstream modulatory mechanisms is important for understanding the regulation of the apoptotic process. Recent findings suggest that differential expression of the caspase-3 gene may underlie regulation of apoptotic susceptibility during brain development, as well as after acute injury to mature brain (18) (19) (20) (21) . Furthermore, previous studies, including our own, demonstrated significant increases in transcriptional activity of the caspase-3 gene during neuronal apoptosis after various stimuli (12, 13, (22) (23) (24) (25) (26) (27) (28) (29) . Therefore, in addition to regulation of proteolytic activation, a potential rate-limiting step leading to regulation of caspase-3 activity may be transcription of this gene.
This report provides first information on the rat caspase-3 gene control region and general transcription factors required for transcription activity of this gene.
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EXPERIMENTAL PROCEDURES
Cloning of the rat caspase-3 gene promoter-The P1 Rattus norvegicus genomic DNA library DNA from a PCR-positive P1 clone was isolated, digested with BamHI or HindIII restriction endonucleases and subcloned in pZErO-2 plasmid vector (Invitrogen, Inc.). A hundred recombinant DNA clones were screened using a 32 P-labeled oligonucleotide 5'-GGGCGGTAGGCTGCTGATGC-3'corresponding to exon 1 of the rat caspase-3 gene.
Hybridization was performed at moderate stringency (6 SSPE, 0.2% SDS at 37°C). Individual positive clones were isolated after an additional round of colony purification at the same hybridization stringency. Isolated clones were then analyzed by restriction mapping with numerous restriction endonucleases and PCR followed by sequencing using the chain termination reaction.
5'-RACE-was performed using Marathon-Ready" cDNA from Sprague-Dawley rat brain (BD Biosciences Clontech) according to manufacturers recommendations. In brief, 5 µl of a cDNA sample was subjected to the first round of PCR amplification using the adaptor primer 1 (AP1) and the antisense caspase-3 primer 5'-CATTTCTTTAGTGATAAAA-3'. After amplification for 30 cycles (94°C, 30 s; 55°C, 15 s; 72°C, 2 m), the reaction products were diluted 20-fold
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with water, and 3 µl was then reamplified for 30 cycles using the same reaction conditions with nested primer AP2 and the antisense caspase-3 primer 5'-ATCATGGGATCTGTTTCTTT-3'.
The longest detected PCR products were then cloned in the pCR2.1 TA-cloning vector (Invitrogen) and sequenced by the chain termination reaction. Progressive deletion constructs of the caspase-3 promoter were engineered by unidirectional cloning of PCR fragments from the promoter between the NheI and HindIII sites of the reporter luciferase vector pGL3-basic (Promega). Nucleotide sequences of the cloned DNA fragments were confirmed in each case using the chain termination sequencing reaction.
Primer extension analysis-
PC12 or HeLa cells were seeded into 6-well plates and transiently transfected using Mirus
TransIT-100 reagent (Panvera). Transfections included reporter plasmids and pRSV²-galactosidase reporter vector (Promega) as an internal control. After 24 hr, cells were harvested and lysates were analyzed for luciferase activity by using the enhanced luciferase assay kit (Analytical Luminescence Laboratory, San Diego) and a TD-20/20 Luminometer. For ²-galactosidase activity the luminescent ²-galactosidase genetic reporter system (Clontech) was used.
Reverse transcription-PCRThe levels of mRNA were analyzed with an RT-PCR approach, as previously described (31) . In brief, total cellular RNA was isolated by acidic phenol extraction The cDNA for GAPDH was used as the internal control. Primers to amplify rat GAPDH cDNA were 5'-TAAAGGGCATCCTGGGCTACACT-3' (sense primer) and 5'-TTACTCCTTGGAGGCCATGTAGG-3' (antisense primer). GAPDH cDNA was amplified for 22 cycles at PCR conditions described for caspase-3 cDNA. The identity of each PCRgenerated product to a corresponding cDNA has been confirmed by DNA sequencing (12) .
Nuclear ExtractsRat brains were dissected on ice and immediately homogenized in lysis buffer (50 mM Tris·HCl, pH 7.5, 1.5 mM MgCl 2 , 200 mM sucrose, 0.1% Triton X-100, 2 mM 2-mercaptoethanol, 10 mM NaF, and 0.5 mM phenylmethylsulfonyl fluoride) and incubated on ice for 5 min. Nuclei were pelleted by centrifugation at 1,600 × g for 5 min at 4°C and washed twice
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in lysis buffer without Triton X-100. Nuclear proteins were extracted in high salt buffer (420 mM KCl, 50 mM Tris·HCl, pH 7.5, 5 mM MgCl 2, 10% sucrose, 20% glycerol, 1 mM EDTA, 2 mM DTT, 20 mM NaF, 0.5 mM phenylmethylsulfonyl fluoride, 0.1 µg/ml leupeptin, 5 µg/ml antipain, and 5 µg/ml aprotinin) by gentle mixing at 4°C for 30 min. Debris was pelleted by centrifugation at 14,000 × g for 15 min.
Binding assay for Ets-1 transcription factors  Affinity purification of nuclear proteins was 
proteins (Santa Cruz Biotechnology).
Liu et al. Analysis of the 5'-flanking sequence using PromoterInspector software (Genomatix Software GmbH, Munich) resulted in prediction of a core promoter region between 1637 and 1932 nt. The predicted core promoter lacks an apparent TATA-box and contains six Sp1 and one GC box binding sites.
RESULTS
Identification
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Determination of a transcription start site Based on the sequence previously obtained by 5-RACE (GenBank U58656), we next determined locations of the transcription start points for the caspase-3 gene. The target mRNA was isolated from fetal rat brain because our previous results
showed high levels of caspase-3 mRNA expression in this tissue (21) . The primer extension reaction gave rise to multiple extension products that corresponded to a sequence extending from 6 to 12 nt upstream of that determined by us in 5'-RACE experiments (Fig. 2) . The most extended transcription start site for caspase-3 mRNA from rat fetal brain can, thus, be assigned to a G nucleotide 87 bp upstream from the first splicing site. All positions within the rat 5'-flanking sequence have been indexed relative to this +1 transcription start site (Fig. 1 ). promoter activity (Fig. 5B ).
Functional characterization of the rat caspase-3 5'-flanking region
To confirm a functional role of the Ets-1 element, three additional 10 bp-deletions were introduced in the 5'-end of the promoter beginning with -1646 nt. The resulting reporter constructs were transfected in PC12 cells. Results of the luciferase assay evidently showed that a small deletion of Ets-1 binding region (from nt -1646 to nt -1636) was sufficient for loss of promoter activity (Fig. 5C ). by Western blot using antibodies specific to Tel protein (Fig.6) . Results showed that a wild type but not a mutant Ets-1 binding site was able to bind with this member of Ets-1 transcription factors.
Tel member of Ets-1 family binds to the caspase-3 gene promoter
Activation of caspase-3 promoter by growth factor deprivation Using semi-quantitative RT-
PCR, we examined the effect of growth factor deprivation on caspase-3 mRNA levels in differentiated PC12 cells. Thus, the cells in complete medium were treated with 100 ng/ml NGF (Sigma) for 5 days followed by removal of NGF and serum. As shown in figure 7A , such treatment caused a significant elevation in caspase-3 mRNA after 6 h. Addition of NGF to serum-free culture medium prevented an increase in caspase-3 mRNA levels. NGF did not significantly affect caspase-3 mRNA levels in the presence of serum.
To examine whether activity of the caspase-3 promoter is affected by growth factor deprivation, PC12 cells were transiently transfected with (-1646/88)-luciferase reporter plasmid and luciferase activity was assayed after 24 h incubation with or without serum or NGF. Results demonstrated an approximately 70% increase in luciferase activity in the absence of serum and NGF compared to activity in the presence of serum, NGF, or both (Fig.7B) .
A DNA fragment comprising the promoter sequence from -1646 nt to +88 nt was then growth factor-deprived conditions (Fig.7C) .
In order to confirm that activation of the caspase-3 promoter leads to increase in protein levels, we examined EGFP protein expression in transfected PC12 cells as a function of time after growth factor deprivation. Using Western blot analysis we found that EGFP protein levels were elevated after 6 hr of treatment (Fig.7D) . PromoterInspector software (Genomatix) resulted in prediction of a core promoter region between 425068 and 425487 nt. Alignment of the rat and human predicted core promoters using LALIGN showed 61.8% identity within a 225 nt overlap (Fig.8) . Further analysis of the predicted human core promoter using MatInspector demonstrated that, similar to the rat core promoter, it lacks an apparent TATA-box but contains five Sp1 and one GC box binding sites.
Using CLUSTAL W and LALIGN sequence alignment programs we also found that a fragment from 422177 nt to 422942 nt had 61.7% identity within a 788 nt overlap with the cloned rat caspase-3 gene regulatory region. This fragment is located approximately 2.5 Kb upstream from the transcription start site (data not shown).
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DISCUSSION
Previous studies have demonstrated upregulation of caspase-3 gene activity during the course of apoptosis in neuronal cells; however, the significance of such gene activation remains obscure (12, 13, (24) (25) (26) (27) (28) (29) . In this report we identified the rat caspase-3 gene promoter, determined its structure, and began examining mechanisms of its regulation. The study was undertaken in order to test a general hypothesis that differential regulation of caspase-3 gene may have functional consequences for control of neuronal death.
Screening of a P1 rat genomic DNA library resulted in isolation of a 5'-flanking region of the rat caspase-3 gene. Computer analysis of the nucleotide sequence from this fragment predicted, with high probability, a core promoter located between nt -205 and +91 relative to the most upstream transcription start site. This predicted core promoter does not contain a noticeable TATA box but has a cluster of Sp1 binding sites. Absence of a TATA box is a notable feature of many housekeeping genes (37) . In TATA-less promoters, so-called initiator elements, located over a transcription start site, determine basal levels of transcription. In the case of the rat caspase-3 gene, we identified a cluster of transcription start sites. The most upsrem transcription start site identified is located in the middle of a Sp1 tandem.
Using homology analysis tools we found that a predicted promoter for human caspase-3
shows 61.8% identity with the identified rat promoter, also lacks an apparent TATA-box, and contains multiple Sp1 and one GC binding sites. Moreover, we found that the 5' flanking sequence of the human gene demonstrates 61.7% identity with the rat gene regulatory region.
Overall, these data suggest that regulatory regions of the caspase-3 gene are conserved between
Liu et al. these mammalian species.
A recent study has demonstrated that inhibition of Sp1 and Sp3 binding by mithramycin A inhibited neuronal apoptosis induced by oxidative stress or DNA damage (36) . The authors suggested that mithramycin A and its structural analogs might be useful for the treatment of neurological diseases associated with apoptosis. In the present study, we examined an effect of mithramycin A on activity of the rat caspase-3 gene promoter. Results demonstrated that addition of this drug leads to a significant concentration-dependent inhibition of caspase-3 promoter activity.
Elevation of caspase-3 mRNA and protein levels has been reported for several models of neuronal apoptosis (12, 13, (24) (25) (26) (27) (28) (29) . In this study, using PC12 cells, we showed that growth factor deprivation also results in an increase in caspase-3 mRNA content and that this event is associated with activation of the gene specific promoter in cells undergoing apoptosis.
Results of the deletion analysis demonstrated that the computer-predicted caspase-3 core promoter is necessary for expression of the luciferase reporter gene; however, activity of the isolated core promoter is extremely low. cells, stably transfected with the reporter construct described above, underwent apoptosis after growth factor deprivation. Thirty µg aliquots of cytosolic extracts isolated from control and growth factor-deprived cells were subjected to 12% SDS-PAGE and transferred to a nitrocellulose filters. The filters were probed with a monoclonal anti-GFP antibody (Clontech). 
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